CVS Health moved -0.3% this afternoon session, trading between a high of $69.7 and a low of $68.53 per share. Yesterday the stock finished at $69.82 per share, compared to an average analyst target price of $90.54.
CVS Health Corporation provides health services in the United States. The large-cap retail-drug stores and proprietary stores company is based in the United States, and over the last twelve months it has returned a dividend yield of 3.3%. CVS Health has trailing twelve months earnings per share (EPS) of 2.19, which at today's prices amounts to a price to earnings (P/E) ratio of 31.8.
Based on its expected future earnings growth, the company has a price to earnings growth (PEG) ratio of 1.86. Usually a PEG ratio between 0 and 1 indicates a potentially undervalued company.
Overview of the Company's Gross Margins:
| Date Reported | Revenue ($ k) | Cost of Revenue ($ k) | Gross Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2022-02-09 | 292,111,000 | -240,063,000 | 18 | 0.0 |
| 2021-02-16 | 268,706,000 | -219,660,000 | 18 | 0.0 |
| 2020-02-18 | 256,776,000 | -211,248,000 | 18 | 12.5 |
| 2019-02-28 | 194,579,000 | -163,041,000 | 16 | 6.67 |
| 2018-02-14 | 184,786,000 | -156,258,000 | 15 | -6.25 |
| 2017-02-09 | 177,546,000 | -148,712,000 | 16 |
CVS Health's 16.8% average gross margins are thinner than the 23.25% average of the Pharmaceutical Retail industry, implying that the firm might be lacking in competitivity.
